Research Evidence
Proprietary studies, NHS materials, military-study analysis, third-party literature, and conventional footcare critique.
Research Evidence
Proprietary Studies
Key rule: Present as functional/physiological evidence (Tier 2), not RCT-level clinical proof. These measure what the foot does differently — not treatment outcome studies.
Previously documented studies (from Monograph — source files not yet in this folder):
- F-Scan plantar surface area study (8-week, 15 subjects, significant surface area reduction)
- Motion capture great toe dorsiflexion study (12 police officers, 51.43% pre-forefoot strike increase)
- sEMG whole-body muscle activation study (5-minute and 6-week findings)
- University of Huddersfield pilot study (foot length/arch shortening)
- Structural strength comparisons (8.07–50.5% improvement vs. orthotics' 2.97–7.55%)
Documents now in this folder:
2018 Study 6 Biofeedback Insole Usage Creates Morphological Changes to Foot Structure.pdf
- Method: F-Scan in-shoe pressure mapping (Tekscan Inc.)
- Participants: N=12 adult males, 25–40, non-symptomatic
- Results: Average 32.40% reduction in plantar surface area (filtered); 100% of subjects showed reduction; range 9.8%–55.63%
- Conclusion: Morphological changes to foot structure attributable to strengthening of foot's support musculature
- Comparison: Barefoot transition studies show ~50% plantar surface reduction — BFS approaching barefoot outcomes
- Status: Pre-clinical / pilot
2018 Study 7 Consumers Embrace New Insole Based on Bio-Feedback and Foot Strengthening.pdf
- Method: Prospective cohort; factory workers with reported symptoms
- Participants: N=194; bunion sufferers (49), foot fatigue (50), knee pain (48), low back pain (48); 2-week trial
- Results: 57.7% rated experience positive; 54.4% perceived pain reduction; 55.5% reported improved walking with reduced pain
- Product note: "Dynapro Insole" — manufactured to specification of US Patent 5,404,659 (same patent as Barefoot Science)
- Caveat: Short duration; researchers note alignment benefits would likely increase significantly over 6–8 weeks
2018 Study 8 Biofeedback Insole Usage Produces Improved Gait Kinematics.pdf
- Method: FootTrak motion capture (rearfoot kinematic analysis)
- Participants: N=1 adult male, age 36; tested across 5 shoes with and without insole
- Results: Average max pronation reduced from 16.5° to 7.4° (44.85% reduction); total pronation reduced 49.57%; propulsion position shifted from 8.3° pronated to 3.4° supinated takeoff
- Status: Pilot study
2018 Study 12 Plantar Surface Area of the Foot Reduced Through Use of Biofeedback Insole.pdf
- Method: F-Scan in-shoe pressure mapping; published in Biomechanics magazine, October 2001
- Participants: N=15, ages 21–45, 7 male / 8 female, moderate activity level
- Results: Significant difference in barefoot walking (P >0.05); trends in static shod (p=0.069) and walking shod (p=0.082)
- Conclusion: Insole use reduces plantar surface area; changes attributable to foot musculature strengthening
- Note: Web-archived version of the study data; see
biomechanics mag.docxfor the full published article
biomechanics mag.docx ← THE PUBLISHED PEER-REVIEWED ARTICLE — READ THIS
- Full citation: Burke R, Reyes R, Bompa T. "Insole System Decreases Plantar Surface Area." Biomechanics: The Magazine of Body Movement and Medicine, Vol. VIII No. 10, October 2001, pp. 85–93
- Authors: Rob Burke BScKin (Trusatech, Barrie ON); Reggie Reyes BKin (Peak Applied Research, Toronto ON); Tudor Bompa PhD (Tudor Bompa Training System, Sharon ON)
- IMPORTANT — Tudor Bompa connection: Bompa is a named author on this published study AND separately gave a written professional endorsement (see 10-testimonials/Medical Professional Testimonials.docx). He is both researcher and endorser. This strengthens his credibility as an authority figure.
- Design: 8-week F-Scan study; N=15 (7M/8F, ages 21–45); two experiments: (1) experimental vs. control group comparison; (2) proportional surface area change over time
- Key results:
- Significant plantar surface area decrease in barefoot walking condition (P >0.05)
- Unshod walking condition showed dramatic decrease
- Shod walking: ~10% reduction in surface area
- Conclusion: "The decrease in plantar surface area over time can be attributed to the use of the Barefoot Science foot strengthening system insole"
- Huddersfield reference: Article explicitly cites the University of Huddersfield pilot study as prior work, confirming it preceded this publication
- Robbins & Hanna reference: Cites Robbins SE, Hanna AM. "Running-Related injury prevention through barefoot adaptations." Med Sci Sport Exerc 1987;19(2):148-156 — a peer-reviewed paper worth adding to third-party-literature/
- Key quote (for content): "The problem with these solutions [cushioning, orthotics, motion control] is that they attack the symptoms, not the cause, of the problem. This leads to a further weakening of the structure as well as increased dependence on the artificial support."
- ⚠️ MECHANISM LANGUAGE WARNING: The 2001 article describes the mechanism using "windlass effect" and lists tibialis anterior, peroneus tertius, adductor hallucis, and extensor hallucis longus. This is the conventional framing of the time and does not reflect Roy's corrected sesamoid locking mechanism / extrinsic stirrup system understanding. When citing this article, cite the FINDINGS (surface area reduction data) only — do not echo the 2001 mechanism description. See MASTER-SCHEMA.md for the corrected mechanism.
Noraxon USA | Motor Patterns and Pathologies – Installment #4.pdf ← PRIMARY VERSION
- Source: Noraxon USA's own website (the world leader in biomechanical/neuromuscular testing technology)
- Author: David M. Lemke, NMT, sEMG Tech; keynote presenter at Noraxon biomechanics conference
- sEMG case: 15-year-old female distance runner; shin splints, hip pain, previously fitted with custom orthotics
- Before BFS: Left gluteus maximus not firing; left biceps femoris intermittent; lumbar paraspinals contracting asymmetrically
- After 6 weeks BFS (with increased running mileage): Robust symmetrical contraction pattern across all muscles
- Context: Lemke introduced 30+ clients to insoles post-conference; recording sEMG changes systematically
Noraxen EMG data.pdf — duplicate of above (plain text version, different archive source)
Motor Patterns & Pathologies – Part 4... BioPerformance Texas.pdf — same article republished on third-party site; includes Lemke's extended account of his own knee injury (anticipated surgical intervention) resolving within 5 weeks of BFS use
biomechanics mag.pdf
- Original Biomechanics magazine print article (October 2001) — image-based PDF, retained as archive copy
- Full text now available in
biomechanics mag.docx(Word export) — use the .docx version for all content work
TEGH Pain study.doc ← FLAGSHIP CLINICAL STUDY — HIGH PRIORITY FOR CONTENT
- Full title: "Effect of a Foot-Strengthening System Among Emergency Department Personnel"
- Author: Dr. Peter Fowler MD FRCS(C) (Chief Medical Officer, Aspetar, Qatar Orthopedic and Sport Medicine Hospital)
- Co-author: Mary Neill RN MA
- Study design and protocols: Roy Gardiner and Mary Neill; reviewed and approved by Peter Fowler
- Data collection and oversight: Mary Neill RN MA
- Accuracy review: Ned Amendola MD (Director, University of Iowa Sports Medicine) — brought in by Fowler to review for accuracy; notably a former student of Fowler's at the University of Western Ontario who went on to head Iowa's Sports Medicine department
- Independent statistical analysis: McDougall Scientific Ltd, MSL Statistical Consultants, November 2007
- Ethics approval: Research Ethics Board, Toronto East General Hospital ← institutional validation
- NOTE FOR CONTENT: Fowler is the named author. Roy Gardiner and Mary Neill designed the protocols; Fowler reviewed and approved them and the final draft, and brought in Amendola for additional accuracy review. The Fowler–Amendola relationship (mentor and former student, both now in senior orthopaedic sports medicine roles) adds context to the professional calibre of the validation.
- Design: Prospective cohort, participants as own controls; 1-week baseline + 4 weeks wearing FSS
- Setting: Emergency Department, large Toronto hospital (name withheld for staff privacy)
- Participants: N=47 entered; 43 submitted pain logs ≥1 week; 24 completed both week 1 and week 5; nurses (59.6%), doctors (6.4%), administrative/other (34%); 80.9% female; ~50% overweight or obese; ~51% had pre-existing foot problems
- Statistical method: SAS 9.1.3; random coefficient regression model; paired t-tests
- Key results (Week 1 → Week 5):
- Foot pain: −33.0% (p=0.003)
- Knee pain: −42.9% (p=0.001)
- Lower back pain: −34.0% (p=0.016)
- Shoulder pain: −38.9% (p=0.008)
- General fatigue: −22.7% (p=0.003)
- Foot tiredness: −41.7% (p=0.0002)
- Knee tiredness: −51.8% (p=0.0014)
- Lower back tiredness: −44.1% (p=0.0017)
- Declining trend across ALL body parts across all 5 weeks (regression p<0.05 for every measurement)
- Self-reported: 90.3% rated experience "great" or "good"; 75% decline in foot tiredness; 75% decline in foot pain; 70.8% decline in general fatigue
- Why this study matters:
- Ethics board approved — institutional credibility, not proprietary claim
- Independent statistical analysis — McDougall Scientific Ltd; not conducted by Barefoot Science
- Peter Fowler as named author — the same Fowler who chairs the Medical Advisory Board and gave written endorsement. He reviewed and approved the study protocols (designed by Roy Gardiner and Mary Neill) and the final draft, bringing in Ned Amendola MD for additional accuracy review. Amendola is a former student of Fowler's at UWO who went on to direct the University of Iowa Sports Medicine department — the professional relationship adds context to why Fowler chose him as the accuracy reviewer. Fowler's authorship across the TEGH study, combined with his Advisory Board chairmanship and written endorsement, makes him the single most credentialed figure associated with the Barefoot Science evidence base.
- Kinetic chain evidence — a foot stimulus produced statistically significant reductions in knee, back, and shoulder pain. This is the kinetic chain argument supported by clinical data in a real working environment.
- Real-world setting — overweight, high-stress hospital workers with pre-existing conditions, not a controlled lab sample
- References within this study worth noting:
- Cites Burke/Reyes/Bompa Biomechanics 2001 article (reference 9) — confirms the evidence chain
- Cites Landorf & Keenan (reference 13) — the same researcher whose 2006 RCT (in our conventional-critique folder) showed orthotics have no long-term benefit
- McKenzie DC et al. "Running shoes, orthotics, and injuries." Sports Med 1985;2:334-347 — worth adding to third-party-literature/
BFS Monograph copy.pdf
- PDF copy of the Biopods Monograph ("Foot Care Steps in a New Direction," copyright 2007)
- Already fully read in docx format — this is a reference copy
- See 01-science-framework/ for all Monograph-derived content
Schema entries: See MASTER-SCHEMA.md — F-Scan Study, Motion Capture Study, sEMG Study, Structural Strength Comparison, Huddersfield Study
NHS Study
Contents: Neil Frame DPodM MChS study (2012–2015, Stockport NHS Foundation Trust), NHS Innovation England publication (June 2016), 999/1000 patient preference finding, Terence David Moore patient testimony, data disappearance sequence.
Source materials to add here:
- biopods-nhs-study-page.docx (from Documents/Claude) — full factual account for website
- biopods-nhs-content-versions.docx (from Documents/Claude) — four ready-to-use formats
- Any primary source documents (NHS Innovation England archived page, Neil Frame correspondence, Terence Moore letter)
Key rule: Use verbatim formats from biopods-nhs-content-versions.docx only. Do not paraphrase the study description or findings. Present data disappearance as documented fact; draw no conclusions.
Cross-reference — researcher credibility:
See 06-authority-assets/nhs-recognition/neil-frame-physio-first-conference-nov-2014.pdf — a third-party published record (PhysioPod UK, archived May 2015) of Neil Frame presenting Barefoot Science to physiotherapy professionals at the Scottish Physio First Conference in November 2014, during the study period. Independent corroboration of his credentials (MChS SRCh DPodM, WalkinCentre, Cheshire) and active clinical advocacy for Barefoot Science before the NHS publication.
Schema entries: See MASTER-SCHEMA.md — NHS Clinical Study
Sherman et al. Military Study
Contents: US Army prospective study, 1,132 male recruits, Spenco Polysorb arch-supporting insoles, findings of increased injury rate in insole group (38%) vs control (29%).
Source materials to add here:
- Relevant Monograph section with full study details
- Original Sherman et al. paper if available
Key finding: Level 1 evidence that conventional arch-supporting insoles cause harm under load. Insert group had higher lower-limb injury rate than the group wearing plain, unaltered footwear. Authors stated data strongly suggested passive inserts may have actively caused lower extremity injuries.
Schema entries: See MASTER-SCHEMA.md — Sherman et al. Military Study
Third-Party Literature
Purpose: Published research and authoritative writing supporting the Biopods scientific framework. Add new studies here after every blog post. Log each addition in 00-schema/NEW-CONTENT-LOG.md.
Documents now in this folder:
shulman-1949-survey-unshod-feet-china-india-5128-subjects.pdf ← HIGH VALUE
- Citation: Shulman SB. "Survey in China and India of Feet That Have Never Worn Shoes." Journal of the National Association of Chiropodists, Vol. 49, 1949, pp. 26-30
- Design: Survey of 5,128 lifelong barefoot individuals (3,906 China, 1,222 India); all ages 4–87
- Key findings: Only 2.34% weak foot; only 1.09% congenital pes planus (flat foot); remarkably low rates of all foot pathology
- Significance: The definitive pre-modern habitually shod baseline. These subjects had NEVER worn shoes — their gait and tissue adaptation is a true natural baseline, unlike modern "barefoot" studies of habitually shod subjects. The contrast with shod-population pathology rates is stark.
- Content use: Priority support for the Habitually Shod Baseline Error argument; pediatrics content; Quality of Science article
rossi-why-shoes-make-normal-gait-impossible.pdf
- Author: Dr. William A. Rossi, DPM (American Podiatrist & Footwear researcher)
- Article: "Why Shoes Make 'Normal' Gait Impossible" (Podiatry Management)
- Key quote: "Natural gait is biomechanically impossible for any shoe-wearing person. Natural gait and shoes are biomechanically incompatible."
- Argument: Shoes convert natural foot stance, postural alignment, body balance, equilibrium, body mechanics, and weight distribution — making true natural gait unrecoverable while shoes are worn
- Significance: A credentialed podiatrist independently validating the habitually shod baseline error
- Cross-reference: Same author as the Australasian distributor page quote (06-authority-assets/endorsements/)
- Content use: Habitually shod baseline error; conventional critique; science framework content
rossi-footwear-primary-cause-foot-disorders.pdf
- Author: Dr. William A. Rossi, DPM
- Article: "Footwear: The Primary Cause of Foot Disorders" — Part 2 (Podiatry Management)
- Content: Systematic review of how elevated heels alter biomechanics; weight distribution changes (50/50 barefoot → forward-shifted shod); cascading effects on posture and gait
- Content use: Conventional footwear critique; 08-conventional-footcare/ content
rossi-children-footwear-launching-site-adult-foot-ills.pdf
- Author: Dr. William A. Rossi, DPM
- Article: "Children's Footwear: Launching Site for Adult Foot Ills" (Podiatry Management)
- Argument: Children's footwear causes lifelong foot pathology; "by the time the average shoe-wearing child has reached the age of seven or eight, his or her feet clearly reveal a visible loss of anatomical and functional normality"
- Key claim: "All (99 percent) of juvenile footwear, regardless of price or brand, is 'improper' and 'ill-fitting'"
- Content use: Pediatrics content; habitually shod baseline error; conventional critique
rossi-fashion-and-foot-deformation.pdf
- Author: Dr. William A. Rossi, DPM
- Article: "Fashion and Foot Deformation" (Podiatry Management)
- Content: Fashion footwear as a driver of foot pathology; the gap between podiatric advice and public behaviour
- Content use: Broader footwear/culture content; conventional critique framing
wikler-1961-take-off-your-shoes-and-walk.htm
- Author: Simon J. Wikler, D.S.C.
- Source: Extract from out-of-print book published 1961 by Devin-Adair
- Content: Historical argument for barefoot foot health; shoes as incompatible with natural foot function
- Content use: Historical context; conventional footwear critique
malka-osteoporosis-bone-remodeling-wolff-law.htm
- Author: Dr. Jeffrey S. Malka, MD, FACS, FAAOS
- Content: "Bones are alive! Bone is a living tissue… constantly changes in response to mechanical, hormonal, genetic influences"
- Significance: Orthopaedic surgeon independently confirming the biological basis of Wolff's Law
- Content use: Biological Shapeshifting / Wolff's Law support; Biopods stimulus driving bone adaptation
polakoff-repetitive-stress-injuries.htm
- Author: Phillip L. Polakoff, MD
- Source: Integrated Health Management Associates
- Content: Repetitive stress injuries as occupational health issue
- Relevance: Marginal — supports occupational/workplace foot health angle if needed
Previously documented studies (PDFs not yet filed):
| Study | Finding | Relevance |
|---|---|---|
| McKeon et al. (2015) — BJSM — "The Foot Core System" | Intrinsic foot muscles act like lumbo-pelvic core; conventional shoes cause foot core shutdown | Foot strengthening framework |
| Curtis et al. (2021) — Scientific Reports | 57% increase in intrinsic foot flexor strength with minimal footwear over 6 months | Davis's Law / Wolff's Law |
| Cheung et al. (2016/2017) | 11.9% increase in forefoot muscle volume via MRI after transition from cushioned shoes | Muscle recruitment restored when support removed |
| Barres et al. (2012) — Cell Metabolism | Single exercise session → 10% less PGC-1α methylation → increased gene expression at 3 hours | Epigenetic plasticity |
| Lindholm et al. (2018) — Nature Scientific Reports | Lifelong exercisers show lasting promoter hypomethylation in metabolic/contractile/oxidative genes | Epigenetic plasticity |
| Ornish (2008) — PubMed | 90 days lifestyle change → 500+ genes altered; no pharmacological intervention | Epigenetic plasticity |
Action needed: Source and file PDFs for the above studies.
Additional reference to source (cited in Biomechanics Oct 2001 article):
- Robbins SE, Hanna AM. "Running-Related injury prevention through barefoot adaptations." Medicine & Science in Sports & Exercise 1987;19(2):148-156 — peer-reviewed paper on barefoot adaptation cited as foundational support for the BFS mechanism. Worth adding here once sourced.
Conventional Critique
Purpose: Third-party published evidence demonstrating the failure of conventional orthotics and the low quality of podiatric research. The foundation of the Quality of Science Argument — the most important strategic content for Barefootscience.ai.
The orthotic x-ray finding (verbatim from Monograph):
"In every instance, the orthotics had little or no effect on the relative alignment or structural integrity of the interlocking bones, specifically in the midfoot… The only appreciable change observed in the relative alignment was strictly a result of the increased heel height… In all instances, the bones of the foot remained 'unlocked,' and functionally unstable."
Documents in this folder:
turlik-kushner-2000-levels-of-evidence-podiatric-journals.pdf ← CORNERSTONE DOCUMENT
- Full citation: Turlik MA, Kushner D. "Levels of Evidence of Articles in Podiatric Medical Journals." J Am Podiatr Med Assoc 90(6): 300-302, 2000
- Authors: Michael A. Turlik DPM (Dean of Clinical Affairs, Ohio College of Podiatric Medicine); Donald Kushner DPM (Chairman, Department of Podiatric Medicine, Ohio College of Podiatric Medicine)
- Journals reviewed: JAPMA and Journal of Foot and Ankle Surgery, years 1993 and 1998
- Total articles reviewed: 322
Verbatim abstract finding:
"The authors reviewed 322 articles in podiatric medical journals to determine their level of evidence. Only 1% of the articles reviewed were randomized controlled trials. The authors concluded that if the podiatric medical profession wishes to become a participant in evidence-based medicine, greater emphasis must be placed on studies that assess hypotheses."
Verbatim Discussion finding:
"Of the published articles reviewed in this study, 1% presented what would be considered level 1 evidence. A large majority of the published articles reviewed dealt with generating, rather than testing, hypotheses."
Exact breakdown from Table 2:
| Type of Article | Total | % |
|---|---|---|
| Randomized controlled trial | 4 | 1% |
| Cohort study | 7 | 2% |
| Case-control study | 15 | 5% |
| Case series | 103 | 32% |
| Case report | 116 | 36% |
| Literature review | 39 | 12% |
| Animal/cadaver study | 20 | 6% |
| Unclassified | 18 | 6% |
| Total | 322 | 100% |
- No meta-analyses published in either journal for either year reviewed
- Case series + case report together = 68% of all articles (confirmed verbatim in body: "which together accounted for 68% of all of the articles published")
- Evidence level 1 (RCT/meta-analysis) = 1% — "the weakest categories of evidence" dominate
Significance: The entire conventional podiatric evidence base is built predominantly on uncontrolled case reports and case series — the weakest evidence categories (levels 4–5). This is the foundational citation for the Quality of Science Argument on Barefootscience.ai.
Use: When conventional practitioners invoke "the evidence," this paper — published in the profession's own journal, by its own academics — is the response. Cite the verbatim abstract finding above; do not paraphrase.
joseph-2000-JAPMA-editor-response-turlik-kushner.pdf ← FULL TEXT HELD — READ THIS FIRST
- Full citation: Joseph WS. "Podiatric Medical Research" [From the Editor]. J Am Podiatr Med Assoc 90(6): 279-280, 2000
- Author: Warren S. Joseph, DPM — Editor, Journal of the American Podiatric Medical Association
- What it is: The JAPMA Editor's own editorial published in the same issue as Turlik & Kushner (June 2000), responding directly to their findings
This document is the most rhetorically powerful in the entire folder. The Editor of the journal in which the Turlik & Kushner paper was published used his editorial to confirm the findings, explain why the problem is structural, and state he sees no significant change coming. This is the establishment indicting itself.
Key verbatim quotes:
On how long this has been known:
"This has been a refrain of critics of the podiatric medical literature for as long as anyone can remember. It is a frequent topic of discussion on Internet listserves and at continuing medical education conferences. Anyone who has ever served on an editorial board of one of the profession's journals has heard derogatory comments about the abundance of case reports."
On the structural cause:
"The problem rests more in the overall structure of the profession than in any particular component."
"In podiatric medicine we lack a 'critical mass' of trained researcher-authors. If one were to combine all of the faculties (full and part time) of all of the colleges of podiatric medicine, the result would be fewer people than in an internal-medicine department at a single medical school."
On the outlook:
"There is no easy solution, and I see no significant change coming."
On his own agreement with Turlik & Kushner:
"I agree with Drs. Turlik and Kushner that, if we wish to participate in the world of evidence-based medicine, our profession must become more active in the performance and publication of significant original research."
Strategic significance: This editorial transforms the Turlik & Kushner finding from a one-off academic critique into a confirmed, longstanding, structural problem — acknowledged by the profession's own journal editor in the same breath as the paper was published. The phrase "I see no significant change coming" is particularly usable: it means the 1% figure is not a temporary state being actively corrected but a chronic structural condition of the field.
Use: Open or close the quality-of-science argument with this editorial. It provides the human voice of the establishment confirming what the data shows — and admitting the profession cannot fix it. Do not paraphrase; use verbatim quotes as above.
paci-2011-evidence-levels-physical-rehabilitation-medicine-journals.pdf
- Full citation: Paci M, Briganti G, Lombardi B. "Levels of evidence of articles published in Physical and Rehabilitation Medicine journals." J Rehabil Med 2011; 43: 264–267
- Authors: Matteo Paci PT MSc (Prato Hospital); Gennaro Briganti MD; Bruna Lombardi MD — Department of Rehabilitation Medicine, Italy
- Scope: 7 major international PRM journals (AJPMR, APMR, Clinical Rehabilitation, Disability and Rehabilitation, EJPRM, IJRR, JRM), 2004–2009
- Total articles reviewed: 5,451
Verbatim abstract findings:
"A total of 5,451 articles were included in this study, of which 636 (11.7%) were randomized controlled trials. Articles published with the highest frequency were those classified as Level III (n=2,424, 44.5%), whereas 'systematic reviews' were the least frequent (n=164, 3.0%). No increase in articles with a high level of evidence was found in the selected journals over the period of study."
Verbatim conclusion:
"The distribution of different types of article in Physical and Rehabilitation Medicine journals is similar to that in other disciplines. There has been no increase in articles with a high level of evidence published in the selected journals over the time-period analysed."
Exact breakdown (Table II):
| Level | n | % | Type |
|---|---|---|---|
| Level I | 636 | 11.7% | Randomized controlled trials |
| Level II | 269 | 4.9% | Controlled clinical trials |
| Level III | 2,424 | 44.5% | Cohort, observational, descriptive |
| Level IV | 478 | 8.8% | Case report/series (<10 subjects) |
| Systematic reviews | 164 | 3.0% | Meta-analysis, systematic reviews |
| Non-systematic reviews | 307 | 5.6% | Narrative reviews |
| Validation studies | 847 | 15.5% | — |
| Others | 326 | 6.0% | — |
| Total | 5,451 |
Strategic significance for the Quality of Science Argument:
This paper extends the evidence quality problem beyond podiatry to the entire Physical and Rehabilitation Medicine field — the broader set of disciplines (physiotherapy, rehabilitation medicine, sports medicine) that treat the conditions Biopods addresses. Even in this broader field, only 11.7% of articles are RCTs — and the situation was not improving over time. Podiatry (1% RCTs, per Turlik & Kushner 2000) is dramatically worse than even this low baseline.
The paper also cites similar findings in sports medicine (Bleakley & MacAuley 2002, Br J Sports Med) and orthopaedics (Obremskey et al. 2005, J Bone Joint Surg) — suggesting this is a systemic failure across every discipline relevant to foot and musculoskeletal health.
Use: Companion citation to Turlik & Kushner. Together they establish that the low evidence quality is not a podiatry-specific anomaly — it is the norm across all relevant fields. Biopods' evidence (NHS study, TEGH clinical study, F-scan data) sits at a higher standard than the typical output of these disciplines.
landorf-2015-methodological-quality-RCTs-JAPMA-1999-2013.pdf ← FULL TEXT HELD
- Full citation: Landorf KB, Menz HB, Armstrong DG, Herbert RD. "Methodological Quality of Randomized Trials Published in the Journal of the American Podiatric Medical Association, 1999–2013." J Am Podiatr Med Assoc 105(4): 320-329, 2015
- Authors: Karl B. Landorf PhD, Hylton B. Menz PhD (La Trobe University); David G. Armstrong DPM MD PhD (University of Arizona); Robert D. Herbert PhD (Neuroscience Research Australia)
- Scope: All 1,143 articles published in JAPMA, January 1999 – December 2013; 44 randomized trials identified and assessed using the validated PEDro scale (0–10)
Verbatim abstract findings:
"A total of 1,143 articles were published in JAPMA between January 1999 and December 2013. Of these, 44 articles were reports of randomized trials. Although the number of randomized trials published each year increased, there was only minimal improvement in their methodological quality (mean rate of improvement = 0.01 points per year). The methodological quality of the trials studied was typically moderate, with a mean ± SD PEDro score of 5.1 ± 1.5. Although there were a few high-quality randomized trials published in the journal, most (84.1%) scored between 3 and 6."
Verbatim conclusion:
"Although there has been an increase in the number of randomized trials published in JAPMA, there is substantial opportunity for improvement in the methodological quality of trials published in the journal."
Key data points (exact):
- Total articles 1999–2013: 1,143
- Randomized trials: 44 = 3.8% of all articles
- By 5-year period: 2.9% (1999–2003) → 3.6% (2004–2008) → 5.1% (2009–2013) — slight increase, but from near zero
- Mean PEDro score: 5.1 ± 1.5 (out of 10) — "typically moderate"
- 84.1% of trials scored 3–6 (low-to-moderate quality)
- Only 6.8% scored ≥8 (high quality)
- Rate of methodological improvement: 0.01 points per year — "minimal"
- Only 15.9% of trials specified required sample size
- Only 1 trial (of 44) was registered with a clinical trial registry
- 50% had some industry funding; 31.8% funded by the company whose product was being tested
- 22.7% had paid consultants for the company being evaluated
Additional citations this paper provides (worth sourcing):
- Porthouse J, Torgerson DJ. "The need for randomized controlled trials in podiatric medical research." JAPMA 94: 221, 2004 — searched Cochrane database, found only 6 RCTs in podiatric medicine since 1997; concluded "the practice of podiatric medicine is not adequately informed by high-quality evidence"
- Turlik MA, Kushner D, Stock D. "Assessing the validity of published randomized controlled trials in podiatric medical journals." JAPMA 93: 392, 2003 — found podiatric RCTs are less valid than those published in mainstream journals (JAMA)
Strategic significance — the complete narrative this paper establishes:
This paper closes the loop on the evidence quality argument across 15 years. The progression:
- Turlik & Kushner (2000): Only 1% of podiatric articles are RCTs
- Landorf et al. (2015): A decade later, still only 3.8% are RCTs — and even those RCTs are typically only moderate quality (5.1/10)
- Quality improving at 0.01 points per year — the field is essentially static
- Only 1 trial in 15 years was registered with a clinical trial registry
This is not a historical critique — it is current as of 2013 data, published 2015. The conventional podiatric evidence base remains structurally weak, and what little exists is itself of questionable quality.
Use: This is the definitive citation for the "even the RCTs aren't good" layer of the quality-of-science argument. Use after establishing the 1% baseline (Turlik & Kushner) to show that even the trend toward more RCTs hasn't produced trustworthy findings.
barske-baumhauer-2012-quality-research-foot-ankle-publications ← ABSTRACT ONLY (paywalled)
- Full citation: Barske HL, Baumhauer J. "Quality of research and level of evidence in foot and ankle publications." Foot Ankle Int. 2012 Jan;33(1):1-6. DOI: 10.3113/FAI.2012.0001. PMID: 22381229
- Journal: Foot & Ankle International — journal of the American Orthopaedic Foot & Ankle Society (AOFAS). This is the orthopaedic foot and ankle establishment's own journal. Impact Factor 2.2 / 5-year IF 2.8.
- Source held: Abstract only (PubMed + Sage Journals screenshots). Full text restricted access — obtain via institutional access or ResearchGate author request.
- Note: Paper generated Letters to the Editor response: Malay D, Cook EA, Cook JJ, Roukis TS, Kim PJ. Foot Ankle Int. 2012 May;33(5):455; author reply 456. DOI: 10.3113/FAI.2012.0455. PMID: 22735292 — confirms the paper had significant enough impact to generate published peer response.
- Scope: 245 articles from 7 North American orthopedic and podiatric journals, January–June 2010; 128 excluded based on study design; 117 clinical research articles analysed
Verbatim abstract results:
"A total of 245 articles were published, 128 were excluded based on study design, leaving 117 clinical research articles. Seven (6%) were Level I, 14 (12%) Level II, 18 (15%) Level III, and 78 (67%) Level IV. The orthopedic journals published 78 studies on foot and ankle topics. Of the podiatric journals, the Journal of the American Podiatric Medical Association (JAPMA) published 12 clinical studies and the Journal of Foot and Ankle Surgery (JFAS) published 27, 21 (78%) of which were Level IV studies. When the quality of research was examined, few therapeutic studies used validated outcome measures and only 38 of 96 (40%) gathered data prospectively. Thirty (31%) studies used a comparison group."
Verbatim abstract conclusion:
"Foot & Ankle International (FAI) published higher quality studies with a higher LOE as compared to podiatry journals. Regardless of the journal, MDs produced the majority of published clinical foot and ankle research. Although improvements have been made in the quality of some clinical research, this study highlights the need for continued improvement in methodology within foot and ankle literature."
Key data points:
- 67% of clinical foot and ankle articles are Level IV (weakest evidence — case report/series)
- Only 6% are Level I (RCTs)
- JFAS: 78% of its clinical articles are Level IV
- Only 40% of therapeutic studies gathered data prospectively
- Only 31% used a comparison group — meaning 69% have no control whatsoever
Strategic significance: This is a 2012 update confirming the same structural evidence weakness identified by Turlik & Kushner in 2000 — and it focuses specifically on foot and ankle research, the most directly relevant field. Published in the AOFAS's own journal, making this the establishment critiquing itself. The JFAS finding (78% Level IV) is particularly striking. Note: previously mis-catalogued in knowledge base summaries as "Barres et al. 2012."
Action needed: Obtain full PDF if possible (institutional access or author request via ResearchGate).
mattila-2011-orthotics-rct-no-benefit-228-subjects.pdf
- Citation: Mattila VM et al. "Can orthotic insoles prevent lower limb overuse injuries?" Scand J Med Sci Sports. 2011 Dec;21(6):804-8
- Design: Randomized controlled trial, N=228
- Finding: 46.6% of the insole group sustained lower limb overuse injuries vs. 38.1% in the control group (P=0.29); hazard ratio 1.3 for insole group — orthotics slightly increased injury risk
- Conclusion: "Routine use of orthotic insoles does not prevent physical-stress-related lower limb injuries"
- Use: Directly contradicts the conventional rationale for prescribing orthotics for injury prevention
withnall-2006-shock-absorbing-insoles-rct-no-benefit-recruits.pdf
- Citation: Withnall R et al. "Do shock absorbing insoles in recruits undertaking high levels of physical activity reduce lower limb injury?" J R Soc Med. 2006 Jan;99(1):32-7
- Design: Randomized controlled trial, N=1,205 RAF recruits
- Finding: 18.0% injury rate with non-shock-absorbing insoles vs. 18.5% with shock-absorbing insoles (P=0.87) — no difference
- Conclusion: "The trial provides no support for a change in policy to the use of shock absorbing insoles for military recruits"
- Use: RCT evidence that the basic premise of cushioning/shock-absorbing insoles has no clinical support
landorf-2006-foot-orthoses-plantar-fasciitis-rct-no-long-term-benefit.pdf
- Citation: Landorf KB et al. "Effectiveness of foot orthoses to treat plantar fasciitis: a randomized trial." Arch Intern Med. 2006 Jun 26;166(12):1305-10
- Design: Randomized trial, N=135, 12-month follow-up; sham vs. prefabricated vs. custom orthosis
- Finding: Small short-term function benefit at 3 months; NO significant effects on primary outcomes at 12-month review; custom and prefabricated orthoses showed similar effectiveness
- Conclusion: "Foot orthoses produce small short-term benefits in function… but they do not have long-term beneficial effects compared with a sham device"
- Use: The flagship RCT on plantar fasciitis orthotics — and it shows no long-term benefit. Critical for plantar fasciitis content.
aaos-frey-1996-otc-insoles-more-effective-than-custom-orthotics.pdf
- Source: AAOS Orthopaedics Update '96 (American Academy of Orthopaedic Surgeons); Dr. Carol Frey MD, Associate Professor of Orthopaedic Surgery, USC
- Design: 2-month multicentre study, N=240 patients with heel pain
- Finding: Pain relief rates — silicone heel cushion 95%, heel cup 88%, felt pad/arch support 81%, custom orthotics 68%, stretching only 72%
- OTC insoles outperformed custom orthotics
- Frey quote: "Custom-made and over-the-counter orthotics… are often over-prescribed"
- Quote: "Refraining from prescribing expensive $300–$400 custom-made orthotics, when $15–$40 over-the-counter inserts will prevent the pain is common sense"
- Use: From the orthopaedic surgery establishment's own research — custom orthotics are not superior
Shock absorbing insoles and lower limb injury.webarchive
- Likely the same study as Withnall 2006 or related coverage — .webarchive format not easily readable without Safari
- Action needed: Open in Safari to confirm content
ostlie-stpeter-2010-evidence-based-pediatric-surgery ← ABSTRACT ONLY (screenshot)
- Full citation: Ostlie DJ, St Peter SD. "The current state of evidence-based pediatric surgery." J Pediatr Surg. 2010 Oct;45(10):1940-1946
- Journal: Journal of Pediatric Surgery. 41 citations, 47 captures (PlumX metrics).
- Source held: Abstract screenshot only. Full text paywalled.
- Scope: All RCTs in pediatric general surgery (excluding transplant, oncology, subspecialties), January 1999 – December 2009, identified via PubMed
Verbatim results:
"The search criteria produced 56 manuscripts, of which 51 described appropriate randomization techniques. A definitive trial design with a sample size calculation was utilized in only 19 studies (34%). A statistically significant difference between treatment arms was identified in 29 of the 56 (52%) trials. There were 26 different journals of publication… The combined total publications from January 1999 through December 2009 for the 26 journals these randomized trials represent 0.04% of all publications."
Verbatim conclusion:
"The current state of evidence-based surgery in pediatric surgery has remained stable in the first decade of the 21st century. Randomized controlled trials represent less than 0.05% of all publications involving pediatric surgery."
Strategic significance: Contextual / broadening reference. This paper is not directly about podiatry or foot health, but establishes that the evidence quality problem is pervasive across medicine — with RCTs representing less than 0.05% of all pediatric surgery publications. Podiatry at 1% (Turlik & Kushner) looks relatively better only by comparison to this extreme. The broader point for content: conventional medicine, including surgery, routinely makes treatment decisions without RCT-level evidence — foot care is not an outlier, it is a symptom of a wider structural problem.
Usage note: Use as contextual support, not a primary citation. The podiatric-specific papers (Turlik & Kushner, Landorf et al., Barske & Baumhauer) are the primary citations for the cornerstone argument. This paper supports the "this isn't just podiatry" framing if needed, but should not be the lead.
turlik-kushner-stock-2003-validity-RCTs-podiatric-journals.pdf ← FULL TEXT HELD
- Full citation: Turlik MA, Kushner D, Stock D. "Assessing the Validity of Published Randomized Controlled Trials in Podiatric Medical Journals." J Am Podiatr Med Assoc 93(5): 392-398, 2003
- Authors: Michael A. Turlik DPM (private practice, Beachwood OH); Donald Kushner DPM (Ohio College of Podiatric Medicine); Dina Stock DPM (Ohio College of Podiatric Medicine)
- What it is: The direct follow-up to Turlik & Kushner (2000). Where the 2000 paper established the quantity problem (only 1% of articles are RCTs), this 2003 paper goes deeper: it assesses the quality of the RCTs that do exist, comparing them head-to-head against JAMA RCTs on nine validated validity categories.
- Scope: 10 years of JAPMA and JFAS reviewed backward from December 2000; 9 podiatric RCTs identified and selected (7 from JAPMA, 2 from JFAS). Matched against 9 RCTs from JAMA (first 4 months of 2001). Each article assessed on 9 validity categories = 81 total measurements per group.
Verbatim abstract finding:
"The results of the study indicate that randomized controlled trials published in podiatric medical journals are less credible than those published in a mainstream medical journal."
Verbatim conclusion:
"The quantity of RCTs published by podiatric physicians in podiatric medical journals is limited, and the quality is lower than in mainstream medicine. It is important for podiatric physicians to produce pragmatic, valid, and definitive RCTs to demonstrate the effectiveness and safety of therapeutic interventions unique to podiatric medicine."
Core result (exact):
- Podiatric journal articles: satisfactory explanations on 26 of 81 validity questions = 32%
- JAMA articles: satisfactory explanations on 67 of 81 validity questions = 83%
- χ² = 42.4; df = 1; P < .001
Category-by-category breakdown (Table 2 — exact figures):
| Validation Question | Podiatric (Yes) | Podiatric (No) | JAMA (Yes) | JAMA (No) |
|---|---|---|---|---|
| 1. Randomization explained | 2 | 7 | 5 | 4 |
| 2. Concealment allocation explained | 0 | 9 | 3 | 6 |
| 3. Groups comparable at baseline | 5 | 4 | 9 | 0 |
| 4. All patients accounted for | 4 | 5 | 9 | 0 |
| 5. Assessors of outcomes blinded | 2 | 7 | 8 | 1 |
| 6. Outcome instrument validated | 4 | 5 | 9 | 0 |
| 7. Sample size calculated beforehand | 1 | 8 | 8 | 1 |
| 8. Statistical analysis appropriate | 7 | 2 | 9 | 0 |
| 9. 95% CI calculated | 1 | 8 | 7 | 2 |
| Total | 26 | 55 | 67 | 14 |
The most damning individual findings:
- Zero podiatric articles had acceptable concealment allocation (Q2) — the single most important bias-prevention mechanism in an RCT
- Only 1 of 9 podiatric articles calculated sample size beforehand (Q7) — meaning 8 of 9 RCTs were likely underpowered
- Only 1 of 9 presented 95% confidence intervals (Q9) — meaning results cannot be meaningfully interpreted for clinical use
- Only 2 of 9 adequately described randomization (Q1) — the defining feature of an RCT
Additional context from the paper:
- Interrater agreement was high (κ = 0.80–0.86, all P < .001) — the quality assessments are reliable
- "Even if the podiatric medical journal articles were not methodologically flawed, none of the trials could be judged as definitive."
- 9 RCTs were found across 10 years of two podiatric journals; JAMA published 9 RCTs in its first four months of 2001
- The paper directly references Turlik & Kushner (2000) as the predecessor establishing the quantity problem
Strategic significance — this paper closes the quantity/quality loop:
The argument now has two layers from the same research team, in the same journal:
- Turlik & Kushner (2000): The evidence base is 99% case reports and series — only 1% are RCTs
- Turlik, Kushner & Stock (2003): The 1% that are RCTs don't meet basic methodological standards — only 32% satisfactory vs JAMA's 83%, P < .001, with zero acceptable on the single most critical validity measure
The profession cannot escape this with "we just need more RCTs" — the RCTs they produce are themselves of insufficient quality to support clinical decision-making.
Use: Deploy after establishing the 1% baseline. The sequence is: not enough RCTs (2000) → and the ones that exist aren't credible (2003) → and 15 years later it hasn't meaningfully improved (Landorf et al. 2015). Three papers, same journal, same authors on two of them — the profession documenting its own evidentiary failure across 15 years.
menz-2001-publication-patterns-podiatric-faculty-JAPMA.pdf ← CONTEXTUAL/SUPPORTING
- Full citation: Menz HB. "Publication Patterns and Perceptions of the Australian Podiatric Medical Faculty." J Am Podiatr Med Assoc 91(4): 210-218, 2001
- Author: Hylton B. Menz, BPod(Hons) — Associate Lecturer, University of Western Sydney–Macarthur. Note: This is the same Hylton B. Menz PhD who, 14 years later, co-authored Landorf et al. (2015) as a senior researcher at La Trobe University — his career arc tracks the state of the field.
- What it is: A survey of publication productivity and journal perceptions of all full- and part-time podiatric medical faculty in Australia (n=27, response rate 90%).
- Relevance: Not a critique of evidence quality directly, but provides hard data on why the evidence quality is so low — the profession lacks the academic infrastructure to produce it.
Key findings (exact):
- Publication productivity: average 0.7 papers per staff member per year — "considerably less than that of medical school faculty members (average rates of publication ranging from 1.5 to 3.9)"
- 37% of faculty had published no papers at all
- Most papers published in local, low-prestige journals not indexed in MEDLINE: Australasian Journal of Podiatric Medicine (38%), British Journal of Podiatry (17%)
- Only 14% of publications appeared in JAPMA — the field's flagship journal
- Faculty themselves rated MEDLINE inclusion as the most important criterion for selecting a journal — yet most published in non-MEDLINE journals
Why it matters for the Quality of Science Argument:
This paper provides the structural explanation for what Joseph (2000) diagnosed as a "lack of critical mass of trained researcher-authors." The data here gives that diagnosis empirical substance: a third of academic faculty had never published, and average output was half the rate of comparable medical school faculty. The profession is not generating the researcher pipeline needed to produce high-quality evidence.
Acknowledgment note: Menz thanks "Karl B. Landorf, DipAppSc(Pod), GradDipEd" for manuscript assistance — Landorf is the lead author of the 2015 RCT quality paper already in this folder. Both Menz and Landorf were early in their careers at this point; by 2015 they were the profession's leading evidence-quality researchers, still documenting the same structural problem.
Use: Background/contextual reference. Use to support the structural explanation layer of the quality-of-science argument — the Joseph editorial identifies the problem, this paper quantifies the underlying cause. Not a primary citation for the cornerstone article, but useful if the piece goes deep on why the evidence is thin.
Previously documented (not yet filed as separate documents):
- Orthotic x-ray study (from Monograph pp. 46–49): Figures 73–81; in every instance orthotics left bones unlocked and structurally unstable
- Habitually Shod Baseline Error: see notes/0004-gemini-exploration-insights.md and MASTER-SCHEMA.md
- Permanent Splint Paradox: progressive atrophy from passive support — documented in Monograph
Schema entries: See MASTER-SCHEMA.md — Orthotic X-Ray Study, Turlik & Kushner, Habitually Shod Baseline Error, Quality of Science Argument
Educational content only. This page is not a diagnosis, prescription, or substitute for care from a qualified clinician.